These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10828741)

  • 21. A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes.
    Berkovich A; McPhie P; Campagnone M; Guidotti A; Hensley P
    Mol Pharmacol; 1990 Feb; 37(2):164-72. PubMed ID: 2154668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic exposure of cells expressing recombinant GABAA receptors to benzodiazepine antagonist flumazenil enhances the maximum number of benzodiazepine binding sites.
    Pericić D; Lazić J; Jembrek MJ; Strac DS; Rajcan I
    Life Sci; 2004 Dec; 76(3):303-17. PubMed ID: 15531382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of inhalational anesthetics on in vivo and in vitro benzodiazepine receptor binding in the rat cerebral cortex.
    Hansen TD; Warner DS; Todd MM; Baker MT; Jensen NF
    Anesthesiology; 1991 Jan; 74(1):97-104. PubMed ID: 1846065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Honokiol and magnolol selectively interact with GABAA receptor subtypes in vitro.
    Ai J; Wang X; Nielsen M
    Pharmacology; 2001 Jul; 63(1):34-41. PubMed ID: 11408830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET: central benzodiazepine neuroreceptor mapping in generalized epilepsies.
    Savic I
    Adv Neurol; 2000; 83():137-44. PubMed ID: 10999195
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708.
    Atack JR; Alder L; Cook SM; Smith AJ; McKernan RM
    Neuropharmacology; 2005 Aug; 49(2):220-9. PubMed ID: 15996568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xenon does not affect gamma-aminobutyric acid type A receptor binding in humans.
    Salmi E; Laitio RM; Aalto S; Maksimow AT; Långsjö JW; Kaisti KK; Aantaa R; Oikonen V; Metsähonkala L; Någren K; Korpi ER; Scheinin H
    Anesth Analg; 2008 Jan; 106(1):129-34, table of contents. PubMed ID: 18165567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoradiographic localization and binding study of benzodiazepines receptor sites in carp brain (Cyprinus carpio L.).
    Pirone A; Giannaccini G; Betti L; Lucacchini A; Mascia G; Fabbrini L; Italiani P; Uccelli A; Lenzi C; Fabiani O
    J Chem Neuroanat; 2006 Feb; 31(2):139-45. PubMed ID: 16298509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of benzodiazepine binding sites following chronic treatment with flumazenil.
    Pericić D; Jazvinsćak Jembrek M; Svob Strac D; Lazić J; Spoljarić IR
    Eur J Pharmacol; 2005 Jan; 507(1-3):7-13. PubMed ID: 15659288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of pregnancy and lactation on GABA(A) receptor and central-type and peripheral-type benzodiazepine receptors.
    Weizman R; Dagan E; Snyder SH; Gavish M
    Brain Res; 1997 Mar; 752(1-2):307-14. PubMed ID: 9106472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GABA(A) receptor imaging with positron emission tomography in the human newborn: a unique binding pattern.
    Chugani HT; Kumar A; Muzik O
    Pediatr Neurol; 2013 Jun; 48(6):459-62. PubMed ID: 23668871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel GABAA antagonist [3H]SR 95531: microscopic analysis of binding in the rat brain and allosteric modulation by several benzodiazepine and barbiturate receptor ligands.
    McCabe RT; Wamsley JK; Yezuita JP; Olsen RW
    Synapse; 1988; 2(2):163-73. PubMed ID: 2844001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET: central benzodiazepine neuroreceptor mapping in localization-related epilepsies.
    Duncan JS; Koepp MJ
    Adv Neurol; 2000; 83():131-6. PubMed ID: 10999194
    [No Abstract]   [Full Text] [Related]  

  • 34. N'-Phenylindol-3-ylglyoxylohydrazide derivatives: synthesis, structure-activity relationships, molecular modeling studies, and pharmacological action on brain benzodiazepine receptors.
    Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Gesi M; Martini C; Giannaccini G; Lucacchini A
    J Med Chem; 1998 Sep; 41(20):3821-30. PubMed ID: 9748357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vivo autoradiographic benzodiazepine receptor imaging with 125I-iomazenil (Ro 16-0154)].
    Odano I; Nakajima T; Miyashita K; Takahashi N; Fujita M; Naritomi H; Furusawa T; Hayashi S; Sakai K
    Kaku Igaku; 1993 Jul; 30(7):761-7. PubMed ID: 8397310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.
    Lingford-Hughes A; Hume SP; Feeney A; Hirani E; Osman S; Cunningham VJ; Pike VW; Brooks DJ; Nutt DJ
    J Cereb Blood Flow Metab; 2002 Jul; 22(7):878-89. PubMed ID: 12142573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the histidine residue at position 105 in the human alpha 5 containing GABA(A) receptor on the affinity and efficacy of benzodiazepine site ligands.
    Kelly MD; Smith A; Banks G; Wingrove P; Whiting PW; Atack J; Seabrook GR; Maubach KA
    Br J Pharmacol; 2002 Jan; 135(1):248-56. PubMed ID: 11786501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic treatment with flumazenil enhances binding sites for convulsants at recombinant alpha(1)beta(2)gamma(2S) GABA(A) receptors.
    Pericić D; Lazić J; Strac DS
    Biomed Pharmacother; 2005 Aug; 59(7):408-14. PubMed ID: 16084060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.
    Atack JR; Maubach KA; Wafford KA; O'Connor D; Rodrigues AD; Evans DC; Tattersall FD; Chambers MS; MacLeod AM; Eng WS; Ryan C; Hostetler E; Sanabria SM; Gibson RE; Krause S; Burns HD; Hargreaves RJ; Agrawal NG; McKernan RM; Murphy MG; Gingrich K; Dawson GR; Musson DG; Petty KJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):470-84. PubMed ID: 19704033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methodological aspects for in vitro characterization of receptor binding using 11C-labeled receptor ligands: a detailed study with the benzodiazepine receptor antagonist [11C]Ro 15-1788.
    Sihver W; Sihver S; Bergström M; Murata T; Matsumura K; Onoe H; Andersson Y; Bjurling P; Fasth KJ; Westerberg G; Ogren M; Jacobsson G; Lundqvist H; Oreland L; Watanabe Y; Långström B
    Nucl Med Biol; 1997 Nov; 24(8):723-31. PubMed ID: 9428597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.